Skip to content

Clinical trials

Terminated Lymphoma, Large B-Cell, Diffuse trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Terminated Country / region: United States Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20033
20049
200510
200612
20079
200812
20098
20109
20117
20124
201311
20146
201514
201615
201711
20189
20194
20208
20217
202210
202312
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated210

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
Fred Hutchinson Cancer Center9
City of Hope Medical Center7
Seagen Inc.7
Masonic Cancer Center, University of Minnesota6
OHSU Knight Cancer Institute6
Pfizer6
Vanderbilt-Ingram Cancer Center5
ADC Therapeutics S.A.4
Case Comprehensive Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse210
Lymphoma, Follicular111
Lymphoma, Non-Hodgkin110
Lymphoma, Mantle-Cell107
Leukemia, Lymphocytic, Chronic, B-Cell96
Lymphoma84
Burkitt Lymphoma79
Lymphoma, B-Cell, Marginal Zone79
Precursor Cell Lymphoblastic Leukemia-Lymphoma75
Lymphoma, Large-Cell, Immunoblastic60

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.